MiSeq i100 Series cancer research

The MiSeq i100 Series is well suited for targeted translational cancer research workflows such as targeted DNA variant analysis, RNA fusion detection, solid tumor profiling, hematologic malignancy research, hereditary cancer research, liquid biopsy and cfDNA studies, and cancer biomarker discovery.

The MiSeq i100 Series makes targeted cancer sequencing studies fast, simple, and accessible without sacrificing data quality. MiSeq i100 Series can do same-day targeted DNA and RNA sequencing for solid tumors, hematologic malignancies, hereditary cancer, and liquid biopsy research with simplified workflows and onboard analysis.

The MiSeq i100 Series was designed for both new and experienced users with its streamlined operations, from easy setup to onboard data analysis. Run setup requires only three steps and can be completed in less than 20 minutes. Integrated reagent cartridges offer room temperature ship and storage. Data analysis summaries can be generated in two hours or less for most applications by accessing preconfigured DRAGEN pipelines, either onboard or in the cloud, requiring minimal bioinformatics expertise.

The MiSeq i100 Series has a streamlined workflow that includes expedited setup with room-temperature consumables and intuitive data analysis. Research workflows are available for targeted sequencing of solid and hematological malignancies. Onboard DRAGEN secondary analysis reduces turnaround times to deliver same-day results. Watch how easy it is to set-up a run on the MiSeq i100 Series.

Pillar oncoReveal panels are specifically designed to leverage the MiSeq i100 Series ultrafast turnaround times for somatic mutation profiling studies. For germline research, the TruSight Hereditary Cancer Panel is fully compatible with the MiSeq i100 Series. AmpliSeq for Illumina is ideal for custom-designed small panels or specialized hotspots where you only want to sequence a handful of specific candidate genes.